In the moderate-response group, tirzepatide was again associated with lower rates of nausea, vomiting, and dizziness
Some require immediate attention: Severe, persistent abdominal pain (could be pancreatitis) Signs of dehydration (dark urine, extreme dizziness, cant keep fluids down) Vision changes Severe allergic reactions (throat swelling, difficulty breathing) Continuous vomiting that prevents eating or taking medication Upper right abdominal pain with yellowing skin (gallbladder issues) Dehydration from GI side effects can cause kidney problems
References National Library of Medicine
LY3298176 activated both GIP and GLP-1 receptor signaling in vitro and showed glucose-dependent insulin secretion and improved glucose tolerance by acting on both GIP and GLP-1 receptors in mice
In case of diarrhea, stay hydrated and consult your doctor for over-the-counter medication
Extended exposure during delayed shipping is a different matter